The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Neurological Disorder Diagnostics Market Between 2026 And 2030?
The neurological disorder diagnostics market has experienced robust expansion over recent years. Forecasts indicate this market will grow from $12.61 billion in 2025 to $13.54 billion in 2026, at a compound annual growth rate (CAGR) of 7.3%. The historical growth can be attributed to factors such as the increasing occurrence of neurological disorders, heightened recognition of the importance of early diagnosis, the development of sophisticated imaging infrastructure, increased funding for neurological research, and better access to diagnostic tools.
The neurological disorder diagnostics market is projected for substantial expansion in the coming years, reaching a valuation of $17.75 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This expansion during the forecast period is primarily driven by factors such as the increasing embrace of precision neurology approaches, greater investments in digital diagnostics platforms, the broadening scope of personalized treatment planning, the expanding utilization of tele-neurology services, and progress in neuroinformatics and analytics. Key trends anticipated in the same period involve a growing uptake of AI-assisted neuroimaging tools, a rise in the application of biomarker-based diagnostic kits, increased integration of genetic and molecular testing methods, the proliferation of remote and digital cognitive assessments, and a heightened emphasis on the early detection of diseases.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19611&type=smp
What Significant Factors Are Influencing The Neurological Disorder Diagnostics Market Expansion?
The escalating incidence of Alzheimer’s disease is projected to fuel the expansion of the neurological disorder diagnostics market in the coming years. Alzheimer’s disease is identified as a progressive neurodegenerative condition marked by a slow deterioration of cognitive abilities, such as memory, logical thinking, and problem-solving. Its development involves a combination of elements, including genetic predispositions like specific gene mutations and variations, the build-up of amyloid plaques and tau tangles within the brain, persistent inflammation, circulatory problems, and lifestyle choices. Neurological disorder diagnostics aid in addressing Alzheimer’s disease by facilitating timely and precise identification through sophisticated imaging methods, biomarker analysis, and cognitive evaluations. For example, in September 2024, data from the Australian Institute of Health and Welfare, an Australia-based government body, indicated that approximately 411,100 individuals in Australia were living with dementia in 2023, comprising about 257,500 women and 153,700 men. Consequently, the rising prevalence of Alzheimer’s disease is propelling the growth of the neurological disorder diagnostics market.
How Is The Neurological Disorder Diagnostics Market Organized By Segment Classification?
The neurological disorder diagnostics market covered in this report is segmented –
1) By Component: Instruments, Reagents, Kits, Software, Services
2) By Technology: Immunoassay, Polymerase Chain Reaction (PCR) Techniques
3) By Disease Type: Alzheimer’s Disease, Dementia, Parkinson’s Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types
4) By End User: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes
Subsegments:
1) By Instruments: Electroencephalography (EEG) Machines, Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Lumbar Puncture Equipment, Ultrasound Devices, Neurostimulation Devices, Transcranial Magnetic Stimulation (TMS) Devices,
2) By Reagents: Biochemical Reagents, Antibodies, DNA Probes, RNA Probes, Enzyme-linked Immunosorbent Assay (ELISA) Reagents, Polymerase Chain Reaction (PCR) Reagents, Sample Collection Reagents
3) By Kits: Diagnostic Test Kits, Genetic Testing Kits, Biomarker Detection Kits, Immunoassay Kits, Point-of-Care Testing Kits, Screening Kits for Neurological Disorders
4) By Software: Diagnostic Software for Imaging Analysis, Data Management Software, Clinical Decision Support Software, Patient Management Software, Laboratory Information Management Systems (LIMS), Neuroinformatics Software, Telemedicine Software
5) By Services: Diagnostic Testing Services, Consultation Services, Training and Support Services, Maintenance and Repair Services for Equipment, Telehealth Services, Data Analysis Services, Research and Development Services
What Trends Are Affecting The Direction Of The Neurological Disorder Diagnostics Market?
Companies operating within the neurological disorder diagnostics market are primarily focused on developing innovative solutions, such as neurological disease quantification software, to address the needs of one billion individuals worldwide affected by neurological diseases. Neurological disease quantification software functions as a tool for measuring and analyzing brain function and the progression of diseases in neurological conditions. For example, in January 2024, Quibim, a biotechnology company from Spain, launched the QP-Brain, an AI-based software designed for quantifying early-stage neurological diseases. QP-Brain by Quibim is advanced neuroimaging analysis software specifically created to quantify changes in brain tissue associated with neurological diseases. Its distinguishing features include AI-powered automated segmentation and detailed volumetric analysis, providing precise insights into alterations in brain structure for both clinical and research applications.
Who Are The Industry Participants Involved In The Neurological Disorder Diagnostics Market?
Major companies operating in the neurological disorder diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co.Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation
Get The Full Neurological Disorder Diagnostics Market Report:
Which Region Is The Largest In The Neurological Disorder Diagnostics Market?
North America was the largest region in the neurological disorder diagnostics market in 2025. The regions covered in the neurological disorder diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Neurological Disorder Diagnostics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Neurological Disorder Diagnostics Market 2026, By The Business Research Company
Central Nervous System Biomarkers Market Report 2026
Clinical Biomarkers Market Report
https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report
Biomarkers Market Report
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model